Abstract
Purpose :
To investigate the influence of rosiglitazone on fibrosis after glaucoma filtration surgery (GFS) through the experiment of human Tenon’s fibroblasts (HTFs) and rabbit GFS model to access the possible mechanism.
Methods :
Cultured human Tenon’s fibroblasts were pretreated in rosiglitazone before being stimulated with transforming growth factor β1 (TGF-β1). Expression of associated targets of autophagy and fibrosis were examined by real-time quantitative RT-PCR, western blot analysis (WB), transmission electron microscope (TEM), immunofluorescence. Trabeculectomy has performed on 30 rabbits that intraocular pressure was in a stable range of 25mmHg to 35mmHg. The operated eyes were followed up within 28 days. After the surgery, immunohistochemistry was performed on D14 and D28, Western blot analysis was performed on D28.
Results :
The experimental group had the least expression of Collagen1, SP1, CTGF, α-SMA, P62 and higher expression of Beclin1, LC3, Vps34, and Atg14L. After GFS on rabbits eyes, the IOP of was significantly lower. The level of Collagen1, SP1, CTGF, α-SMA expression also was reduced in the sclera and conjunctival areas in the rosiglitazone group.
Conclusions :
Rosiglitazone can inhibit the formation of scarring though activate autophagy by Beclin1/Vps34 pathway
This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.